DNA Testing Market Trends | Global Analysis Report 2021

The global DNA Testing market through systematic segmentation that covers every aspect of the target market. The first five-year cumulative revenue (2021–2025) is projected to be over US$ 1,922.0 Bn, which is estimated to increase moderately over the latter part of the five-year forecast period.

DNA testing establishes the absence or presence of a particular sequence of deoxyribonucleic acid by molecular testing methodology. It is present in the genetic or hereditary material present in every cell in the human body. It could also be applied to establish relationships among individuals through a comparison of their respective DNA material.

Get a sample research report for more insights:

Global DNA Testing Market: Market Dynamics

Various chronic and infectious diseases such as cervical cancer, hepatitis B, HIV, and others depend on DNA prototyping for treatment, which has increased the adoption of personalized DNA level diagnostic applications. This is a significant factor expected to fuel the target market’s growth over the next 10 years.

Manufacturing of DNA is a complicated, costly, and time-consuming process. The pre-clinical and clinical stage products may not get approved, leading to an immense loss of investment, efforts, and time. This factor is expected to hamper the growth of the global DNA testing market to a certain extent.

Increasing focus on research and development activities, government support for setting cost-effective facilities in order to expand customer base can provide a beneficial opportunity to manufacturers of DNA Testing.

Global DNA Testing Market: Market Forecast

The comprehensive research report comprises a complete forecast of the global DNA Testing market based on factors affecting the market and their impact in the foreseeable future. According to the forecast projections, revenue from the global DNA Testing market is estimated to expand at a moderate CAGR of 14.1% during the forecast period.

Global DNA Testing Market: Segmental Snapshot

The market report has been segmented based on testing technology, product type, end-users, and region. The testing technology segment includes Microarrays Based, PCR Based, In-Situ Hybridization, & NGS. The product type segment includes DTC Genetic Tests, Traditional Genetic Tests. The end-user segment comprises Ancestry Testing, Diet & Nutrition, Health & Fitness, Disease Risk Assessment, & Other End-Users. The region covered in the analysis is North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

By testing technology: The PCR-based segment is expected to register a CAGR of over 39.1% over the forecast period, thereby accounting for the highest revenue share among the application segments.

By product type: The DTC genetics test segment is expected to register a CAGR of over 68.8%, thereby accounting for the highest revenue share among the type segments.

By end-user: The ancestry testing segment is expected to register a CAGR of over 41.9% over the forecast period, thereby accounting for the highest revenue share among the application segments.

By region: North America’s market accounted for the highest revenue share in the global DNA Testing market in 2018 and is estimated to register a CAGR of over 49.0% between 2019 and 2028.

Global DNA Testing Market: Competitive Analysis

The research report on the global DNA Testing market includes profiles of prominent companies such as Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., LLC, DC Thomson, 23andme, MyHeritage Ltd., DNA Diagnostics Center, Inc., Living DNA Ltd., RSC Health, and Atlas Biomed.

The Global DNA Testing Market: Global Industry, Size, Share, Growth, Trends, and Forecast, 2021–2025 report has been prepared based on an in-depth market analysis with industry experts’ inputs. This report covers the present scenario and the growth prospects of the global DNA Testing Market for 2018–2028.

About Us: is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals who believe strongly in giving our very best to what we do, and we never back down from any challenge. offers services such as data mining, information management, and revenue enhancement solutions and suggestions. We cater to industries, individuals, and organizations worldwide and deliver our offerings in the shortest possible turnaround time.

Like us on Facebook:

Follow on Linkedin:

Contact Us:
Lawrence John
420 Lexington Avenue, Suite 300
New York City, NY 10170,
United States
Tel: +1 347 826 1876
Email ID:

Show More

Rowena Goodwin

I've written about health care for one and a half decades. I wrote for Modern Healthcare and several Iowa newspapers, including the Des Moines Register. I am passionate about health literacy when it comes to explaining the complexities of health care. A better-understood health system may save someone some money or their life.

Related Articles